标题
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-08-05
DOI
10.1038/s41571-020-0413-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Relationship Between the Gut Microbiome and Systemic Chemotherapy
- (2020) Samantha M. Ervin et al. DIGESTIVE DISEASES AND SCIENCES
- Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer
- (2020) Ching-Wei Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PT-112 in advanced metastatic castrate-resistant prostate cancer (mCRPC), as monotherapy or in combination with PD-L1 inhibitor avelumab: Findings from two phase I studies.
- (2020) Alan Haruo Bryce et al. JOURNAL OF CLINICAL ONCOLOGY
- Transdermal cold atmospheric plasma-mediated immune checkpoint blockade therapy
- (2020) Guojun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
- (2020) Isaure Vanmeerbeek et al. OncoImmunology
- PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models
- (2020) Takahiro Yamazaki et al. OncoImmunology
- Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
- (2020) Juliette Humeau et al. EMBO Molecular Medicine
- Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA.
- (2020) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
- (2020) Keisuke Yamamoto et al. NATURE
- Immunotherapy for the first-line treatment of patients with metastatic non-small cell lung cancer
- (2019) Pablo Martinez et al. CLINICAL CANCER RESEARCH
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Maytansine-bearing antibody-drug conjugates induce in vitro hallmarks of immunogenic cell death selectively in antigen-positive target cells
- (2019) Maxine Bauzon et al. OncoImmunology
- Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
- (2019) Jeffrey M. Conroy et al. Journal for ImmunoTherapy of Cancer
- Non‐Thermal Plasma as a Unique Delivery System of Short‐Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells
- (2019) Abraham Lin et al. Advanced Science
- The NKG2A immune checkpoint — a new direction in cancer immunotherapy
- (2019) Benjamin C. Creelan et al. Nature Reviews Clinical Oncology
- Glucocorticoids promote breast cancer metastasis
- (2019) Milan M. S. Obradović et al. NATURE
- Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?
- (2019) Yoshihiro Ohue et al. CANCER SCIENCE
- TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer
- (2019) Jitka Fucikova et al. CLINICAL CANCER RESEARCH
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- Tumor lysis with LTX-401 creates anticancer immunity
- (2019) Wei Xie et al. OncoImmunology
- Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
- (2019) Praveen K. Bommareddy et al. OncoImmunology
- The novel oncolytic compound LTX-401 induces antitumor immune responses in experimental hepatocellular carcinoma
- (2019) Brynjar Mauseth et al. Molecular Therapy-Oncolytics
- Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma
- (2019) EIJI FUKUOKA et al. ANTICANCER RESEARCH
- Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate
- (2019) Si-yuan You et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non–small Cell Lung Cancer Recurrence
- (2019) Max Lacour et al. Clinical Lung Cancer
- Beta blockade as adjunctive breast cancer therapy: A review
- (2019) Sneha Phadke et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
- (2019) Cristina Segovia et al. NATURE MEDICINE
- ErtlFunctionalGroupsFinder: automated rule-based functional group detection with the Chemistry Development Kit (CDK)
- (2019) Sebastian Fritsch et al. Journal of Cheminformatics
- Trial watch: dendritic cell vaccination for cancer immunotherapy
- (2019) Jenny Sprooten et al. OncoImmunology
- Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients
- (2019) Silvia C. Formenti et al. Journal for ImmunoTherapy of Cancer
- Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
- (2019) Robert Chen et al. BLOOD
- An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation
- (2019) Luciano Castiello et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy
- (2019) David A. Schaer et al. CLINICAL CANCER RESEARCH
- CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin
- (2019) Jeanne Galaine et al. INTERNATIONAL JOURNAL OF CANCER
- Nano-encapsulated tryptanthrin derivative for combined anticancer therapy via inhibiting indoleamine 2,3-dioxygenase and inducing immunogenic cell death
- (2019) Canyu Yang et al. Nanomedicine
- Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
- (2019) Heng Yang et al. NATURE MEDICINE
- Pharmacological modulation of nucleic acid sensors — therapeutic potential and persisting obstacles
- (2019) Claire Vanpouille-Box et al. NATURE REVIEWS DRUG DISCOVERY
- Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer
- (2019) So-Jin Park et al. ORAL ONCOLOGY
- Extracorporeal photochemotherapy induces bona fide immunogenic cell death
- (2019) Kazuki Tatsuno et al. Cell Death & Disease
- Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer
- (2019) Ludovic Fournel et al. CANCER LETTERS
- Pre-operative β-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a Phase II randomized trial
- (2019) Jonathan G Hiller et al. CLINICAL CANCER RESEARCH
- Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients
- (2019) Iva Truxova et al. HAEMATOLOGICA
- BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma
- (2019) Miao Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- cGAS/STING axis mediates a topoisomerase II inhibitor–induced tumor immunogenicity
- (2019) Zining Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunosuppression by Mutated Calreticulin Released from Malignant Cells
- (2019) Peng Liu et al. MOLECULAR CELL
- Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice
- (2019) B. R. Loman et al. Scientific Reports
- Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer
- (2019) Anne-Sophie Hamy et al. OncoImmunology
- Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
- (2019) Lenka Kasikova et al. Journal for ImmunoTherapy of Cancer
- Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial
- (2019) Sandra Demaria et al. Journal for ImmunoTherapy of Cancer
- Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells
- (2019) Jinthe Van Loenhout et al. Cancers
- Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma
- (2019) Svetomir N. Markovic et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Medium dose intermittent cyclophosphamide induces immunogenic cell death and cancer cell autonomous type I interferon production in glioma models
- (2019) Bin Du et al. CANCER LETTERS
- Unusual nature of long non-coding RNAs coding for “unusual peptides”
- (2019) Angshuman Bagchi GENE
- Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain
- (2019) Chandran Ramakrishna et al. Scientific Reports
- Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma
- (2018) Stefania Orecchioni et al. BRITISH JOURNAL OF CANCER
- Cytosolic DNA Sensing in Organismal Tumor Control
- (2018) Claire Vanpouille-Box et al. CANCER CELL
- Extracorporeal Photochemotherapy Drives Monocyte-to-Dendritic Cell Maturation to Induce Anticancer Immunity
- (2018) Alessandra Ventura et al. CANCER RESEARCH
- eIF2α phosphorylation is pathognomonic for immunogenic cell death
- (2018) Lucillia Bezu et al. CELL DEATH AND DIFFERENTIATION
- Impact of 5-Fu/oxaliplatin on mouse dendritic cells and synergetic effect with a colon cancer vaccine
- (2018) Xinqiang Hong et al. Chinese Journal of Cancer Research
- Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
- (2018) Dewan Md Sakib Hossain et al. JOURNAL OF CLINICAL INVESTIGATION
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
- (2018) Marina Chiara Garassino et al. LANCET ONCOLOGY
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- The promise and challenges of immune agonist antibody development in cancer
- (2018) Patrick A. Mayes et al. NATURE REVIEWS DRUG DISCOVERY
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combining chemotherapy with PD-1 blockade in NSCLC
- (2018) Matthen Mathew et al. PHARMACOLOGY & THERAPEUTICS
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
- (2018) Laurence Zitvogel et al. SCIENCE
- PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
- (2018) Magalie Dosset et al. OncoImmunology
- Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells
- (2018) A. M. Gravett et al. OncoImmunology
- Targeting adenosine for cancer immunotherapy
- (2018) Robert D. Leone et al. Journal for ImmunoTherapy of Cancer
- STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer
- (2018) Abdi Ghaffari et al. BRITISH JOURNAL OF CANCER
- Prior exposure of pancreatic tumors to [sorafenib + vorinostat] enhances the efficacy of an anti-PD-1 antibody
- (2018) Laurence Booth et al. CANCER BIOLOGY & THERAPY
- Parkin and PINK1 mitigate STING-induced inflammation
- (2018) Danielle A. Sliter et al. NATURE
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
- (2018) Lien Van Hoecke et al. Nature Communications
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non–small cell lung cancer negative for EGFR mutation and ALK fusion
- (2018) Hitomi Sakai et al. LUNG CANCER
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade
- (2018) Silvia C. Formenti et al. NATURE MEDICINE
- Linking cellular stress responses to systemic homeostasis
- (2018) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram
- (2018) Dusana Majera et al. PROSTATE
- Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16
- (2018) Sanjeev Kumar Sagwal et al. Cell Death & Disease
- Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
- (2018) Junghoon Shin et al. Cancer Research and Treatment
- Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity
- (2018) Kathleen M. Kokolus et al. OncoImmunology
- Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer
- (2018) Liam Friel Tremble et al. CANCER LETTERS
- Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
- (2017) Abhishek D. Garg et al. IMMUNOLOGICAL REVIEWS
- High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy
- (2017) Linda Urbanova et al. IMMUNOLOGY LETTERS
- Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide
- (2017) Carla Buccione et al. INTERNATIONAL JOURNAL OF CANCER
- Nanosecond-Pulsed DBD Plasma-Generated Reactive Oxygen Species Trigger Immunogenic Cell Death in A549 Lung Carcinoma Cells through Intracellular Oxidative Stress
- (2017) Abraham Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)
- (2017) Solange Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Carboplatin and programmed death-ligand 1 blockade synergistically produce a similar antitumor effect to carboplatin alone in murine ID8 ovarian cancer model
- (2017) Xinxin Zhu et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Gut microbiota modulation of chemotherapy efficacy and toxicity
- (2017) James L. Alexander et al. Nature Reviews Gastroenterology & Hepatology
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice
- (2017) Romana Mikyskova et al. OncoImmunology
- Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment
- (2017) Chiara Riganti et al. OncoImmunology
- Pro-necrotic molecules impact local immunosurveillance in human breast cancer
- (2017) Gautier Stoll et al. OncoImmunology
- Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death
- (2017) Richard Nuccitelli et al. Journal for ImmunoTherapy of Cancer
- The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer
- (2016) Sylvain Ladoire et al. Autophagy
- Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients
- (2016) J. Fucikova et al. BLOOD
- Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model
- (2016) Yanhong Wu et al. BMC IMMUNOLOGY
- Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
- (2016) Federico Pietrocola et al. CANCER CELL
- Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis
- (2016) Jitka Fucikova et al. CANCER RESEARCH
- Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8+ T Cells
- (2016) E. Beyranvand Nejad et al. CANCER RESEARCH
- The Basis of Oncoimmunology
- (2016) A. Karolina Palucka et al. CELL
- The oncolytic compound LTX-401 targets the Golgi apparatus
- (2016) Heng Zhou et al. CELL DEATH AND DIFFERENTIATION
- The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
- (2016) T Yamazaki et al. CELL DEATH AND DIFFERENTIATION
- The integrated stress response
- (2016) Karolina Pakos‐Zebrucka et al. EMBO REPORTS
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms
- (2016) Hannah R. Wardill et al. MOLECULAR CANCER THERAPEUTICS
- The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death
- (2016) Chiara Pozzi et al. NATURE MEDICINE
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
- (2016) Tania Løve Aaes et al. Cell Reports
- Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy
- (2016) Kei Nakashima et al. Human Vaccines & Immunotherapeutics
- PD-L1 biomarker testing for non-small cell lung cancer: truth or fiction?
- (2016) Claud Grigg et al. Journal for ImmunoTherapy of Cancer
- Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes
- (2015) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells
- (2015) S. Martin et al. BIOCHEMICAL PHARMACOLOGY
- Docetaxel enhances CD3+ CD56+ cytokine-induced killer cells-mediated killing through inducing tumor cells phenotype modulation
- (2015) WenJia Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface-Associated Calreticulin
- (2015) A. M. Dudek-Peri et al. CANCER RESEARCH
- TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
- (2015) Claire Vanpouille-Box et al. CANCER RESEARCH
- Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
- (2015) S. Takeuchi et al. CANCER RESEARCH
- Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor- B to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
- (2015) J. Peng et al. CANCER RESEARCH
- Reactive oxygen species involved in CT26 immunogenic cell death induced by Clostridium difficile toxin B
- (2015) Chunli Sun et al. IMMUNOLOGY LETTERS
- Alkylating Agent Melphalan Augments the Efficacy of Adoptive Immunotherapy Using Tumor-Specific CD4+T Cells
- (2015) Xiaoyun Lu et al. JOURNAL OF IMMUNOLOGY
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Natural and therapy-induced immunosurveillance in breast cancer
- (2015) Guido Kroemer et al. NATURE MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capsaicin-mediated apoptosis of human bladder cancer cells activates dendritic cells via CD91
- (2015) Maria Saveria Gilardini Montani et al. NUTRITION
- RIPK1 and NF- B signaling in dying cells determines cross-priming of CD8+ T cells
- (2015) N. Yatim et al. SCIENCE
- Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
- (2015) E. Vacchelli et al. SCIENCE
- The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells
- (2015) Liv-Marie Eike et al. Oncotarget
- Immunological data from cancer patients treated with Ad5/3 E2F Δ24 GMCSF suggests utility for tumor immunotherapy
- (2015) Otto Hemminki et al. Oncotarget
- PD-1 Restrains Radiotherapy-Induced Abscopal Effect
- (2015) S. S. Park et al. Cancer Immunology Research
- Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
- (2015) Jitka Fucikova et al. Frontiers in Immunology
- Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
- (2015) Holly G. Prigerson et al. JAMA Oncology
- Nanoelectroablation of Murine Tumors Triggers a CD8-Dependent Inhibition of Secondary Tumor Growth
- (2015) Richard Nuccitelli et al. PLoS One
- Treatment of osteosarcoma with microwave thermal ablation to induce immunogenic cell death
- (2015) Zhe Yu et al. Oncotarget
- Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
- (2015) Tiansuo Zhao et al. Oncotarget
- Immunosuppressive Myeloid Cells Induced by Chemotherapy Attenuate Antitumor CD4+ T-Cell Responses through the PD-1-PD-L1 Axis
- (2014) Z.-C. Ding et al. CANCER RESEARCH
- Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing state
- (2014) Miki Tongu et al. CANCER SCIENCE
- Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy
- (2014) Alison M. McDonnell et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis
- (2014) Sarah Dimeloe et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- High hydrostatic pressure induces immunogenic cell death in human tumor cells
- (2014) Jitka Fucikova et al. INTERNATIONAL JOURNAL OF CANCER
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- The key role of calreticulin in immunomodulation induced by chemotherapeutic agents
- (2014) Yoshiyuki Yamamura et al. International Journal of Clinical Oncology
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
- (2014) Abdul Qader Sukkurwala et al. OncoImmunology
- LTX-315 (Oncopore™)
- (2014) Ketil André Camilio et al. OncoImmunology
- ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
- (2013) Abhishek D. Garg et al. Autophagy
- An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors
- (2013) A. C. West et al. CANCER RESEARCH
- CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
- (2013) Yuting Ma et al. CANCER RESEARCH
- Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells
- (2013) Donatella D’Eliseo et al. CELL STRESS & CHAPERONES
- LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma
- (2013) J. T. Yeung et al. CLINICAL CANCER RESEARCH
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
- (2013) Hélène Bugaut et al. PLoS One
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
- (2013) S. Viaud et al. SCIENCE
- Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo
- (2012) Miki Tongu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
- (2012) Hui-Ming Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma
- (2012) S. Miyamoto et al. CANCER RESEARCH
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
- (2012) Abhishek D Garg et al. EMBO JOURNAL
- Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
- (2012) Mélanie Bruchard et al. NATURE MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Effusion Lymphoma Cell Death Induced by Bortezomib and AG 490 Activates Dendritic Cells through CD91
- (2012) Mara Cirone et al. PLoS One
- An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
- (2012) L. Senovilla et al. SCIENCE
- Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
- (2012) L. Menger et al. Science Translational Medicine
- Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin
- (2011) Abhishek D. Garg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release
- (2011) Mladen Korbelik et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
- (2011) J. Fucikova et al. CANCER RESEARCH
- Unraveling Cancer Chemoimmunotherapy Mechanisms by Gene and Protein Expression Profiling of Responses to Cyclophosphamide
- (2011) F. Moschella et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Measles virus causes immunogenic cell death in human melanoma
- (2011) O G Donnelly et al. GENE THERAPY
- Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells
- (2011) Ilenia Pellicciotta et al. GYNECOLOGIC ONCOLOGY
- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
- (2011) Yuting Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Induction of Immunogenic Apoptosis by Blockade of Epidermal Growth Factor Receptor Activation with a Specific Antibody
- (2011) Greta Garrido et al. JOURNAL OF IMMUNOLOGY
- Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas
- (2011) Christoph Bergmann et al. Journal of Translational Medicine
- Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy
- (2011) Ioannis Alagkiozidis et al. Journal of Translational Medicine
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro
- (2010) Jürgen Sonnemann et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients
- (2010) S. Viaud et al. CANCER RESEARCH
- Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
- (2010) G. Schiavoni et al. CANCER RESEARCH
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunization
- (2010) Christine M. Barbon et al. CELLULAR IMMUNOLOGY
- A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
- (2010) K. N. Kodumudi et al. CLINICAL CANCER RESEARCH
- Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
- (2010) Ilia N. Buhtoiarov et al. IMMUNOLOGY
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Classification of Chemotherapeutic Agents Based on Their Differential In vitro Effects on Dendritic Cells
- (2009) H. Tanaka et al. CANCER RESEARCH
- Dual Therapeutic Efficacy of Vinblastine as a Unique Chemotherapeutic Agent Capable of Inducing Dendritic Cell Maturation
- (2009) H. Tanaka et al. CANCER RESEARCH
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
- (2009) Theocharis Panaretakis et al. EMBO JOURNAL
- Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
- (2009) Hanh K. Le et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
- (2008) S. Ladoire et al. CLINICAL CANCER RESEARCH
- Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity
- (2008) Davide Brusa et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started